Ubidecarenone (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ubidecarenone" in Italian language version.

refsWebsite
Global rank Italian rank
4th place
9th place
799th place
22nd place
2nd place
7th place

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • V. Scalori, MG. Alessandrì; M. Mian; L. Giovannini; AA. Bertelli, Plasma and tissue concentrations of coenzyme Q10 in the rat after its oral administration., in Int J Tissue React, vol. 10, n. 2, 1988, pp. 95-7, PMID 3182188.
  • V. Scalori, MG. Alessandrì; L. Giovannini; A. Bertelli, Plasma and tissue concentrations of coenzyme Q10 in the rat after intravenous, oral and topical administrations., in Int J Tissue React, vol. 12, n. 3, 1990, pp. 149-54, PMID 2276892.
  • MG. Alessandrì, V. Scalori; L. Giovannini; M. Mian; AA. Bertelli, Plasma and tissue concentrations of coenzyme Q10 in the rat after intravenous administration by a microsphere delivery system or in a new type of solution., in Int J Tissue React, vol. 10, n. 2, 1988, pp. 99-102, PMID 3182189.
  • MT. Tran, TM. Mitchell; DT. Kennedy; JT. Giles, Role of coenzyme Q10 in chronic heart failure, angina, and hypertension., in Pharmacotherapy, vol. 21, n. 7, Jul 2001, pp. 797-806, PMID 11444576.
  • SM. Greenberg, WH. Frishman, Coenzyme Q10: a new drug for myocardial ischemia?, in Med Clin North Am, vol. 72, n. 1, Jan 1988, pp. 243-58, PMID 3276986.
  • S. Greenberg, WH. Frishman, Co-enzyme Q10: a new drug for cardiovascular disease., in J Clin Pharmacol, vol. 30, n. 7, Jul 1990, pp. 596-608, PMID 2202752.
  • PH. Langsjoen, AM. Langsjoen, Overview of the use of CoQ10 in cardiovascular disease., in Biofactors, vol. 9, n. 2-4, 1999, pp. 273-84, PMID 10416041.
  • S. Pepe, SF. Marasco; SJ. Haas; FL. Sheeran; H. Krum; FL. Rosenfeldt, Coenzyme Q10 in cardiovascular disease., in Mitochondrion, 7 Suppl, Jun 2007, pp. S154-67, DOI:10.1016/j.mito.2007.02.005, PMID 17485243.
  • S. Ogasahara, Y. Nishikawa; S. Yorifuji; F. Soga; Y. Nakamura; M. Takahashi; S. Hashimoto; N. Kono; S. Tarui, Treatment of Kearns-Sayre syndrome with coenzyme Q10., in Neurology, vol. 36, n. 1, Jan 1986, pp. 45-53, PMID 3941783.
  • A. Berio, A. Piazzi, Improvement of Kearns-Sayre syndrome with controlled carbohydrate intake and coenzyme Q10 therapy., in Ophthalmologica, vol. 208, n. 6, 1994, pp. 342-3, PMID 7845654.
  • W. Sperl, [Diagnosis and therapy of mitochondriopathies]., in Wien Klin Wochenschr, vol. 109, n. 3, Feb 1997, pp. 93-9, PMID 9139466.
  • S. Goda, T. Hamada; S. Ishimoto; T. Kobayashi; I. Goto; Y. Kuroiwa, Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy., in J Neurol, vol. 234, n. 1, Jan 1987, pp. 62-3, PMID 3819789.
  • Y. Ihara, R. Namba; S. Kuroda, [A case of mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS)--treatment with coenzyme Q10 and idebenone]., in Rinsho Shinkeigaku, vol. 28, n. 1, Jan 1988, pp. 62-6, PMID 3383514.
  • K. Folkers, R. Simonsen, Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies., in Biochim Biophys Acta, vol. 1271, n. 1, maggio 1995, pp. 281-6, PMID 7599221.
  • CF. Spurney, CT. Rocha; E. Henricson; J. Florence; J. Mayhew; K. Gorni; L. Pasquali; A. Pestronk; GR. Martin; F. Hu; L. Nie, CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy., in Muscle Nerve, vol. 44, n. 2, Aug 2011, pp. 174-8, DOI:10.1002/mus.22047, PMID 21698649.
  • K. Rákóczi, A. Párdutz; L. Vécsei, [Statin drugs decrease the plasma level of coenzyme Q10 (ubiquinone) in the organism]., in Ideggyogy Sz, vol. 60, n. 7-8, Jul 2007, pp. 295-300, PMID 17713110.
  • JJ. Nawarskas, HMG-CoA reductase inhibitors and coenzyme Q10., in Cardiol Rev, vol. 13, n. 2, pp. 76-9, DOI:10.1097/01.crd.0000154790.42283.a1, PMID 15705257.

oadoi.org